seventeen cents by end of october, page-11

re: tide can only be held for a short while The poultry products have made excellent progress, with several successful trials, construction of new vaccine candidates for the Avian Influenza and Coccidiosis diseases and progression through the OGTR regulatory process in Australia. We have an active period scheduled with trials of our new Bird Flu vaccines and poultry Coccidiosis vaccine to occur in the near future.
The commercialisation of the pig vector products was delayed by the uncertainty created by the patent interference process in the US, the major pig products market in the world. The interference has now been successfully resolved in Imugene’s favour, resulting in an improved intellectual property position in the US. With this patent uncertainty resolved, the commercial discussions with potential interested parties have resumed and the pig products research and development has again moved forward.